Skip to content

Yäbulu (Portugal)

Portuguese pharmacovigilance consultancy providing outsourced drug-safety services to marketing-authorisation holders.

Last updated September 29, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Yäbulu is a Portuguese company based in Lisbon that specialises in pharmacovigilance — the science and operational practice of monitoring the safety of medicines after they reach the market. According to its official website, the firm positions itself as a partner for pharmaceutical companies that must comply with the pharmacovigilance obligations attached to a marketing authorisation (AIM). Its stated purpose is to help clients meet legal requirements and the expectations of regulatory inspectors, either by taking on the full range of pharmacovigilance tasks or by providing targeted assistance and consultancy. The company describes pharmacovigilance as a dynamic and constantly changing field in which handling the variety of requests coming from regulatory authorities is demanding both in human and financial terms. Yäbulu therefore offers what it calls value-added services, allowing a marketing-authorisation holder to delegate any or all of its pharmacovigilance workload. The website invites prospective clients who are unsure about which services they need to make contact so that a suitable solution can be found. Yäbulu operates from Lisbon and serves the Portuguese market, with the wider European Union regulatory environment as its natural context. Its public-facing content is in Portuguese, and its service catalogue is organised around pharmacovigilance operations, consulting and support rather than around physical products. The company presents itself as a specialist service provider rather than a manufacturer, and its brand identity is built on regulatory compliance, drug-safety expertise and flexibility for marketing-authorisation holders. Ownership, founding date and executive leadership are not disclosed in the available evidence. The website carries a copyright notice covering 2007–2026, which indicates that the Yäbulu brand has been in use since at least 2007, but no precise incorporation year can be confirmed from the supplied sources. The firm is treated here as a private Portuguese company active in the life-sciences services sector.

History

Yäbulu is a Portuguese company based in Lisbon whose public identity is built around pharmacovigilance services. The available evidence does not record a precise founding date, founders or corporate ownership history. The copyright line on its official website spans 2007–2026, which is the earliest indication of the brand's continuous use and suggests that the business has been operating under the Yäbulu name since at least 2007. From the outset, the company's focus has been the post-authorisation safety obligations of pharmaceutical marketing-authorisation holders. Pharmacovigilance in the European Union is a heavily regulated activity: companies that hold authorisations to market medicines must collect, assess and report adverse-event information, maintain a pharmacovigilance system master file, produce periodic safety update reports and respond to requests from regulators. Yäbulu's website describes this environment as dynamic and constantly changing, and notes that handling the variety of requests from regulatory authorities is demanding both in human and financial terms. Yäbulu's response to that environment is a service model in which a marketing-authorisation holder can delegate all pharmacovigilance tasks or buy only occasional assistance and consultancy. The company frames its offer as value-added services intended to help clients comply with legal requirements and meet the expectations of inspectors. This positions Yäbulu in the outsourced life-sciences services segment, alongside other pharmacovigilance service providers that support smaller or leaner pharmaceutical organisations. The company operates from Lisbon and its public materials are in Portuguese, indicating a primary focus on the Portuguese market within the wider EU regulatory framework. No milestones such as funding rounds, acquisitions, leadership changes or office openings are documented in the supplied evidence, and no parent company or group affiliation is disclosed. The brand remains active, with a website that invites prospective clients to make contact for a tailored solution.

  • Copyright notice on the official website begins in 2007, indicating continuous use of the Yäbulu brand since at least that year.

Products and positioning

Specialist pharmacovigilance service provider helping marketing-authorisation holders meet legal requirements and inspector expectations.

  • Pharmacovigilance outsourcing

    Delegation of pharmacovigilance tasks belonging to a marketing-authorisation holder.

  • Pharmacovigilance consulting and ad-hoc assistance

    Targeted support for companies that need only occasional help with pharmacovigilance obligations.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/yäbulu-portugal · Editorial policy · How profiles are compiled